Annual FCF
-$51.37 M
-$18.54 M-56.45%
31 December 2023
Summary:
Cartesian Therapeutics annual free cash flow is currently -$51.37 million, with the most recent change of -$18.54 million (-56.45%) on 31 December 2023. During the last 3 years, it has fallen by -$85.43 million (-250.79%). RNAC annual FCF is now -250.79% below its all-time high of $34.07 million, reached on 01 December 2020.RNAC Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$7.49 M
+$23.52 M+146.73%
01 September 2024
Summary:
Cartesian Therapeutics quarterly free cash flow is currently $7.49 million, with the most recent change of +$23.52 million (+146.73%) on 01 September 2024. Over the past year, it has increased by +$16.71 million (+181.30%). RNAC quarterly FCF is now -88.53% below its all-time high of $65.35 million, reached on 01 September 2020.RNAC Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$48.41 M
+$16.71 M+25.66%
01 September 2024
Summary:
Cartesian Therapeutics TTM free cash flow is currently -$48.41 million, with the most recent change of +$16.71 million (+25.66%) on 01 September 2024. Over the past year, it has dropped by -$8.33 million (-20.79%). RNAC TTM FCF is now -223.85% below its all-time high of $39.09 million, reached on 01 June 2021.RNAC TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAC Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -56.5% | +181.3% | -20.8% |
| 3 y3 years | -250.8% | +168.7% | -30.2% |
| 5 y5 years | +14.4% | +167.3% | +6.3% |
RNAC Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -250.8% | +16.4% | at high | +123.6% | -79.7% | +28.1% |
| 5 y | 5 years | -250.8% | +16.4% | -88.5% | +123.6% | -223.8% | +28.1% |
| alltime | all time | -250.8% | +16.4% | -88.5% | +123.6% | -223.8% | +28.1% |
Cartesian Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $7.49 M(-146.7%) | -$48.41 M(-25.7%) |
| June 2024 | - | -$16.03 M(-2.9%) | -$65.12 M(+10.4%) |
| Mar 2024 | - | -$16.52 M(-29.3%) | -$58.99 M(+14.8%) |
| Dec 2023 | -$51.37 M(+56.5%) | -$23.35 M(+153.4%) | -$51.37 M(+28.2%) |
| Sept 2023 | - | -$9.21 M(-7.0%) | -$40.08 M(+48.7%) |
| June 2023 | - | -$9.91 M(+11.4%) | -$26.95 M(-8.4%) |
| Mar 2023 | - | -$8.89 M(-26.2%) | -$29.41 M(-10.4%) |
| Dec 2022 | -$32.83 M(-46.6%) | - | - |
| Dec 2022 | - | -$12.06 M(-407.9%) | -$32.83 M(-37.5%) |
| Sept 2022 | - | $3.92 M(-131.7%) | -$52.51 M(-22.0%) |
| June 2022 | - | -$12.37 M(+0.4%) | -$67.34 M(+9.3%) |
| Mar 2022 | - | -$12.32 M(-61.2%) | -$61.63 M(+0.3%) |
| Dec 2021 | -$61.47 M(-280.4%) | -$31.74 M(+190.9%) | -$61.47 M(+65.4%) |
| Sept 2021 | - | -$10.91 M(+63.8%) | -$37.17 M(-195.1%) |
| June 2021 | - | -$6.66 M(-45.2%) | $39.09 M(+15.8%) |
| Mar 2021 | - | -$12.16 M(+63.4%) | $33.74 M(-1.0%) |
| Dec 2020 | $34.07 M(-166.2%) | -$7.44 M(-111.4%) | $34.07 M(+19.1%) |
| Sept 2020 | - | $65.35 M(-644.2%) | $28.59 M(-159.7%) |
| June 2020 | - | -$12.01 M(+1.5%) | -$47.88 M(+11.2%) |
| Mar 2020 | - | -$11.83 M(-8.4%) | -$43.08 M(-16.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$51.48 M(-14.3%) | -$12.91 M(+16.1%) | -$51.48 M(-0.4%) |
| Sept 2019 | - | -$11.13 M(+54.5%) | -$51.69 M(-8.8%) |
| June 2019 | - | -$7.20 M(-64.4%) | -$56.65 M(-15.0%) |
| Mar 2019 | - | -$20.24 M(+54.3%) | -$66.68 M(+11.1%) |
| Dec 2018 | -$60.05 M(+13.8%) | -$13.12 M(-18.5%) | -$60.05 M(+0.5%) |
| Sept 2018 | - | -$16.09 M(-6.6%) | -$59.74 M(+0.9%) |
| June 2018 | - | -$17.24 M(+26.7%) | -$59.21 M(+16.1%) |
| Mar 2018 | - | -$13.60 M(+6.2%) | -$50.99 M(-3.4%) |
| Dec 2017 | -$52.76 M(+159.3%) | -$12.81 M(-17.7%) | -$52.76 M(+36.8%) |
| Sept 2017 | - | -$15.56 M(+72.6%) | -$38.58 M(+34.1%) |
| June 2017 | - | -$9.02 M(-41.4%) | -$28.76 M(+13.2%) |
| Mar 2017 | - | -$15.37 M(-1218.9%) | -$25.41 M(+24.9%) |
| Dec 2016 | -$20.34 M(-13.9%) | $1.37 M(-123.9%) | -$20.34 M(-31.0%) |
| Sept 2016 | - | -$5.74 M(+1.3%) | -$29.49 M(-1.2%) |
| June 2016 | - | -$5.67 M(-45.0%) | -$29.84 M(+3.2%) |
| Mar 2016 | - | -$10.31 M(+32.6%) | -$28.91 M(+22.4%) |
| Dec 2015 | -$23.63 M(+83.0%) | -$7.77 M(+27.6%) | -$23.63 M(+49.0%) |
| Sept 2015 | - | -$6.09 M(+28.4%) | -$15.85 M(+62.4%) |
| June 2015 | - | -$4.74 M(-5.5%) | -$9.76 M(+94.5%) |
| Mar 2015 | - | -$5.02 M | -$5.02 M |
| Dec 2014 | -$12.91 M | - | - |
FAQ
- What is Cartesian Therapeutics annual free cash flow?
- What is the all time high annual FCF for Cartesian Therapeutics?
- What is Cartesian Therapeutics annual FCF year-on-year change?
- What is Cartesian Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Cartesian Therapeutics?
- What is Cartesian Therapeutics quarterly FCF year-on-year change?
- What is Cartesian Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Cartesian Therapeutics?
- What is Cartesian Therapeutics TTM FCF year-on-year change?
What is Cartesian Therapeutics annual free cash flow?
The current annual FCF of RNAC is -$51.37 M
What is the all time high annual FCF for Cartesian Therapeutics?
Cartesian Therapeutics all-time high annual free cash flow is $34.07 M
What is Cartesian Therapeutics annual FCF year-on-year change?
Over the past year, RNAC annual free cash flow has changed by -$18.54 M (-56.45%)
What is Cartesian Therapeutics quarterly free cash flow?
The current quarterly FCF of RNAC is $7.49 M
What is the all time high quarterly FCF for Cartesian Therapeutics?
Cartesian Therapeutics all-time high quarterly free cash flow is $65.35 M
What is Cartesian Therapeutics quarterly FCF year-on-year change?
Over the past year, RNAC quarterly free cash flow has changed by +$16.71 M (+181.30%)
What is Cartesian Therapeutics TTM free cash flow?
The current TTM FCF of RNAC is -$48.41 M
What is the all time high TTM FCF for Cartesian Therapeutics?
Cartesian Therapeutics all-time high TTM free cash flow is $39.09 M
What is Cartesian Therapeutics TTM FCF year-on-year change?
Over the past year, RNAC TTM free cash flow has changed by -$8.33 M (-20.79%)